
|Articles|February 13, 2023
Aenova Moves Partnering with a CDMO to a New Era
Author(s)Aenova
KEY LEARNING OBJECTIVES
- Aenova is a leading global CDMO provider with the widest range of finished dosage forms available.
- Aenova takes its customers' tasks seriously and develops them to the next level in partnering. With Aenova long, reliable partnerships with customers are established.
- With Aenova, new products come to life: Aenova meets the current challenges in innovative drug development and supply and masters the challenges associated with the formulation of molecules, complex therapeutic systems or highly potent active ingredients.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
2
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
3
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5




